神经退行性疾病中的粉样β生物传感器
Mohsen Jabbari Jooshin1, Ghazal Koohkansaadi2, Majid Hassanzadeh-Khanmiri3
1School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinica chimica acta; international journal of clinical chemistry
|September 2, 2025
概括
生物传感器提供检测粉样β (Aβ) 的先进方法,这对于早期诊断阿尔茨海默病至关重要. 这些技术提高了敏感性和特异性,有助于神经退行性疾病的管理和治疗发展.
科学领域:
- 神经科学与生物医学工程
- 关注神经退行性疾病的生物标志物
- 开发先进的诊断工具
背景情况:
- 粉样β (Aβ) 积是阿尔茨海默氏症等神经退行性疾病的关键指标.
- 早期和精确的Aβ检测对于有效的患者管理至关重要.
- 目前的诊断方法需要提高灵敏度和实时监测.
研究的目的:
- 探索生物传感器在检测β粉样蛋白 (Aβ) 中的作用和进步.
- 突出传感器技术增强灵敏度,特异性和实时监控.
- 审查生物传感器平台及其在研究和临床环境中的应用.
主要方法:
- 对基于电化学,光学和纳米材料的生物传感器平台的审查.
- 对Aβ检测的最新技术进展进行分析.
- 检查生物传感器开发和实施的挑战.
主要成果:
- 生物传感器显示了Aβ的增强灵敏度,特异性和实时监测.
- 不同的平台显示出研究和临床应用的前景.
- 主要挑战包括生物相容性,整合和监管障碍.
结论:
- 生物传感器技术具有改善神经退行性疾病管理的巨大潜力.
- 这些工具可以为阿尔茨海默氏症等疾病制定有针对性的治疗策略.
- 需要进一步发展以克服实施挑战.
更多相关视频
相关概念视频
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
03:03Amyloid Fibrils
5.6K
5.6K
01:37Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K